Researchers from the IQS Pharmaceutical Chemistry Group and the Josep Carreras Leukaemia Research Institute are collaborating on the DisX4lymph project to look for new agents for the treatment of aggressive B-cell lymphoma.
Interview with Dr Santi Nonell, tenured professor at the IQS School of Engineering and the university’s first researcher to form part of the ICREA Academia community for excellence in research at Catalan universities.
Dr Oriol Bosch Sanz recently defended his doctoral thesis at IQS, in which he explored obtaining new candidates for inhibitors of the plasminogen/plasmin system to reduce the damage produced in the blood-brain barrier as a result of brain trauma.
Dr Marc Caballé recently defended his doctoral thesis at IQS, in which he explored metabolic engineering as a biological alternative for the production of glycolipids with high biological interest such as α-galactosylceramide.
Four IQS projects have been recognized in the 2022 “Proof of Concept” call to aid them in advancing towards the development, transfer, and exploitation of the results they have achieved in their research.
IQS receives support from the EC to continue and further implement the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers, thus maintaining the HR Excellence in Research Seal reflecting the IQS commitment to continuous improvement of human resources policies.
From 27 to 29 March, IQS hosted the 13th Annual Spanish Carbohydrate Meeting organized by the Specialized Carbohydrate Group with the Spanish Royal Chemistry Society (RSEQ).
IQS researcher Josep Font Moré has earned one of the prestigious grants for University Professor Training, with which he will conduct his doctoral thesis where he will explore the advanced monitoring of the health of structures using Machine Learning tools.
As part of the collaboration agreement between IQS and the scientific instrumentation manufacturer SCIEX, two seminars were recently held to present the company's new high-resolution mass spectrometry (HRMS) instruments and their applications.
The Bioinformatics and Molecular Modeling unit within the IQS Biochemistry Laboratory works on the development and application of computational biology, artificial intelligence, and simulation methods for the discovery and optimization of high added value products for application in various sectors of activity.
Dr Victor Masip recently defended his doctoral thesis at IQS, in which he designed, synthesized, and characterized potential new inhibitors of the ZAP-70 protein for peripheral T lymphoma therapies.
Dr Daniel Jovell recently defended his doctoral thesis at IQS, focused on the design and optimization of fluorinated gas recycling and recovery systems through multi-scale simulation and combining various advanced thermodynamic instruments.
I agree with the Pope when he states that if women could fully enjoy equal opportunity, we would contribute substantially to changing the world towards peace, inclusion, solidarity, and comprehensive sustainability.
Researchers at IQS are conducting pioneering research in the IQS-SCIEX Demo Lab to characterize and purify nucleic acids, the active principal ingredients used to develop new strategies in medicine and therapies.
IQS researcher Maite Molins Colomer has earned a University Professor Training Grant to conduct her doctoral thesis in which she will explore reactions in continuous flow chemistry using autocatalytic copper reactors.
Two female IQS researchers and professors lead two research groups at the university. They are Dr Ana Belén Cuenca, coordinator of the CISOL group, and Dr Meritxell Sáez, coordinator of the ADAMIQS group.
IQS professor Dr Cristina Fornaguera is leading the European project TumorOUT to design a new immunotherapy based on polymer nanoparticles with encapsulated antigenic mRNAs to holistically attack different mechanisms of lung cancer.
“In the Hydrolage project we’re seeking a treatment for osteoarthritis by combining a biomaterial to regenerate cartilage with gene therapy with RNA nanoparticles to treat inflammation.”
On 16 February, the framework collaboration agreement between IQS and the Ona Futura Foundation was signed with the aim of carrying out joint scientific development projects and studying their environmental and social impacts, with a special focus on protecting and regenerating the Mediterranean Sea.
The new Spanish Royal Decree 984/2022 establishes the creation of Knowledge Transfer Offices to enhance connections between knowledge generators and the industrial sector, work that IQS has already been undertaking for a long time.
Led by IQS researchers, the BIOMOD project aims to develop new advanced biomechanical models through 3D techniques to improve surgical practice and the implants used in paediatric maxillofacial surgery.
IQS is leading the European project PoPMeD-SuSDeV, with the goal of establishing a new Population Medicine paradigm and to establish a proactive healthcare model, focused on the early detection of possible disorders and diseases.
“IQS is conducting mechanistic characterization studies of light-emitting particles and the mechanism of light-induced cell death within the Light4Lungs consortium”
Dr Tomás Baldi has recently defended his doctoral thesis at IQS, entitled Manufacturing of nanostructured surfaces by plastic injection molding, in which he managed to obtain nanostructured surfaces through a new plastic injection process.
In her doctoral thesis, Dr Leticia Manén has implemented a chemoinformatics methodology based on the selection of potentially active molecules, going far beyond the processes of hit-to-lead optimization and the claimed Markush space.
IQS is pleased to share the recognition given by AGAUR to the research groups that make up the teaching and research staff at our school, enabling us to affirm that IQS research is extensive and consolidated.
Dr Ariadna Chueca recently defended her doctoral thesis at IQS, in which she provides solutions to overcome the current limitations in additive manufacturing using Fused Filament Fabrication technology and practical recommendations for its use.
IQS researchers are leading the Polycoarct project with the aim of improving current solutions to paediatric aortic coarctation, adapting them to children’s growth, and reducing the number of new surgical interventions.
Dr Nausika Betriu recently defended her doctoral thesis at IQS, in which she studied various aspects related to the progression of pancreatic cancer using physiological models based on three-dimensional cultures.
IQS is one of the members of the DemiRNApy project, one of the 36 research projects selected by the Fundació Marató TV3 charitable fundraising drive in its 2021 edition dedicated to mental health, with the aim of developing nanotherapies to treat depression.
IQS will boast a JEOL nuclear magnetic resonance demo laboratory, a new platform that will feature two state-of-the-art spectrometers with "High Tech" technologies in terms of digital signals and high frequencies.
Thanks to the potential of additive manufacturing, IQS researchers have reproduced a wide range of natural shapes and bio-inspired designs to obtain lighter, more sustainable, and more efficient structural solutions.
Researchers with the Electrometric Methods Laboratory at IQS formed part of FusionCAT, a project that has made it possible to bring a dynamic scientific community together in Catalonia that was able to make rather significant contributions in the field of fusion.
Dr Marc Nel·lo recently defended his doctoral thesis at IQS, in which he developed electrochemical lithium sensors that are suitable for being applied in future fusion reactors, thus opening the doors to advances in this type of energy.
Various IQS researchers are using winning methodologies from the 2022 Nobel Prize in Chemistry in their research in the fields of biomedicine, nanotechnology, and the search for new drugs.
Chance will play a decisive factor among proposals that reach certain minimum quality requirements. This is what the United Kingdom and other countries are proposing in upcoming calls for public grants to fund research.
IQS boasts a Triple Quad™ 7500 LC-MS/MS System – QTRAP® device, the triple quad mass spectrometer with the highest sensitivity SCIEX offers, featuring expansive linear range, precision, and instrumental accuracy.
Dr Félix Friederich defended his doctoral thesis at IQS, based on three studies about the market challenges related to consumer engagement with new digital products.
The GEMAT group at IQS is working on the zwiRNA project with the goal of designing a new state-of-the-art therapeutic vaccine for the treatment of lung cancer.
Seven postdoc researchers will join various IQS research groups thanks to the support of the Investigo Programme, financed through Next Generation EU and Government of Catalonia funding.
IQS Tech Transfer and the Beauty Cluster organize and hold an event featuring innovation as the leading force behind competitiveness in the cosmetics sector.
Dr Meritxell Sáez of IQS is conducting a line of research on "Mathematical modelling of embryonic development biology" with the aim of understanding and predicting decision-making at the cellular level.
"It is essential to have adequate tools in order to study complex systems, and photonics is an ideal discipline considering its non-invasive nature, occupying an essential place in research"
The six IQS projects that have been awarded grants for the next three years, within the framework of the 2021 "Knowledge Generation Projects" call for grants, have a total budget of nearly €830,000. In addition, two of them were also awarded FPI predoctoral grants.
Dr José Antonio Durán defended his doctoral thesis at IQS, in which he developed dressings with hydrogels as platforms for the controlled release of miRNAs for diabetic foot ulcer treatment.
A fantastic success both in terms of attendees and content, IQS hosted and sponsored the 11th meeting of the Paul-Ehrlich Euro-PhD Network, part of the MedChem 2022 Conference.
“In the ADC2GBM project, we're combining our experience in targeted evolution and antibody engineering to develop activatable antibody-drug conjugates for the treatment of glioblastoma multiforme”
IQS has established a wide range of partnerships with scientific equipment suppliers with the goal of promoting advanced research that can lead to results which can be transferred to industry.
IQS recently hosted the first international workshop on the Chinese development model, entitled defying mainstream economic theories to achieve unprecedented progress.
Dr Georgina Curto defended her doctoral thesis entitled "Artificial Intelligence and Inclusion: An Analysis of Bias Against the Poor," a pioneering work that provides empirical evidence about the existence of aporophobia in Artificial Intelligence systems and social networks.
IQS has participated in the European project PROTEOblood, a cross-border project with the aim of studying and seeking new leukaemia and lymphoma treatments through understanding protein degradation and destruction cycles.
Dr Antoni Planas i Sauter has been named a scholar with the 3rd Chemistry section of the RACAB, a very important honour for IQS and one that recognizes the outstanding career of one of its professors.
IQS sponsored the inaugural edition of the Biomedical Glycoscience Summer School, organized by the Specialized Carbohydrates Group with the RSEQ in which over 40 researchers in the field of glycosciences participated.
The CTPTI Bioprocess Pilot Plant at IQS has recently carried out various collaborative efforts with companies on projects and developing innovative products in the fields of biostimulants and alternative proteins.
IQS has a RAMAN DRX2 Microscope instrument for material characterization. This technique makes it possible to obtain information on the chemical composition of organic and inorganic compounds in any material condition and even in aqueous solutions.
Dr Bernat Coll defended his doctoral thesis at IQS on 21 February, in which he characterized the SUMOylation of the Rpn5 protein within the context of the proteasome, with an additional study of protein degradation and the potential of chimeric proteins as therapeutic tools.
"My contribution to the ANTIEMT project is designing genetic material transporters. They are invisible polymers for most of the body's cells, except for tumor cells, to which they are targeted as ‘ninjas.’"
IQS has acquired three chromatography instruments for peptide and protein characterization and purification, with funding from the Fundación “la Caixa” Junior Leader Fellowships programme.
In her doctoral thesis conducted at IQS, Dr Noemí Balà has designed a specific device to treat aortic dissection featuring mechanical properties similar to those of the artery, making it possible to improve current treatments.
The representatives from Givaudan Ibérica were able to take a guided tour of the Bioprocess Pilot Plant, led by Dr Planas himself, where they discovered the possibilities offered by this facility first-hand.
IQS is collaborating with the Food and Agriculture Research and Technology Institute’s (IRTA) Fruit Growing – Agroforestry Group and the Government of Catalonia’s Catalan Forestry Agency to develop an analytical method to detect and quantify Deltamethrin. Deltamethrin is an insecticide in the pyrethroid family used to combat pests in stone pine, currently in the trial phase to control Leptoglossus occidentalis.
"Within the University's Research and Innovation Office – which could be defined as a node, a transit station, or a hub for contacts – we can't help in terms of carrying out projects, but we can act as a transit space to connect different groups at our schools."
Within the field of Advanced Materials, IQS has created various spinoffs thanks to the innovative and entrepreneurial spirit of numerous professors and researchers at the university.These initiatives are a clear example of the importance of knowledge transfer from the academic and higher education world to industry.
The R&D&i services and technology transfer offered by IQS Tech Transfer to companies has grown even greater since the end of 2019 through the launch of the Nanotechnology and Advanced Materials Unit located within the Process Transfer and Integrative Technologies Centre (CTPTI) at IQS.
The Nanotechnology and Advanced Materials Unit within the Process Transfer and Integrative Technology Transfer Centre (CTPTI) at IQS boasts several laboratories equipped for research and technology transfer activities mainly related to particle and cell characterization and the analysis and characterization of polymeric materials, biomaterials, ceramic materials, and graphene, among others.
In collaboration with the consulting firm ASYVAL SL, a conference dedicated to the implementation of data integrity has been held at IQS, a policy that ensures that data and records are complete, consistent, secure and accurate, and that they are available throughout their lifecycle.
IQS participates in the European project NEXTGenPS, with the aim of detecting addictive and potentially hallucinogenic substances and facilitating the implementation of control measures for them in the European Union.
Dr. Mireia Castejón recently defended her doctoral thesis at IQS, where she has managed to obtain the tetrasaccharide compound lacto-N-tetraose, present in breast milk, by enzymatic synthesis. This opens the door to obtaining new biocatalysts for the synthesis of HMO oligosaccharides by this route.
Inside the EUROfusion project, in which IQS researchers participate, the 59 Megajoules fusion energy record was reached for five seconds, a giant leap forward for fusion reaction power generation.
"IQS, and throught the ICT+Tourism promoted by ACCIÓ, aims to help transform the tourism sector through new technologies, bringing them closer to companies and providing them with strategic judgement in using them."
IQS is participating alongside other technological and medical research centers in Barcelona on a highly advanced and pioneering project in Europe to produce and use an artificial placenta to ensure survival for extremely premature newborns.
Is the new labor reform designed to improve the job stability of research staff at universities and research centers? To what extent will the future Law of Science be able to solve its shortages?
Dr Oller from IQS has recently received a grant from the Semilla programme with the Spanish Cancer Society (AECC) to work on new types of activatable antibodies against a specific marker of resistant cancer cells.
Dr Jordi Duran, a researcher of IQS, carries out a project of the study of the physiological role of brain glycogen and its involvement in certain neurodegenerative diseases (pathological role)
"The Business-University relationship must be very close, each one with its needs and way of working, in a complex but necessary balance within this symbiosis, which in the end, echoes positively throughout society"
The company Syva, specialized in animal health, has received the first training course in the design and optimization of bioprocesses, organized by the IQS Bioprocess Pilot Plant.
The IQS spinoff company, Aortyx, has received €2.5 million euros in "Grant first" funding through the European Innovation Council (EIC) Accelerator Programme. Also, Dr Inés Moreno received one of the prestigious Torres Quevedo Grants at the end of 2021 to conduct her research in this spinoff company.
Researchers from IQS and IDAEA-CSIC collaborate in this project for the analysis of neurotoxic compounds present in water, using advanced methodologies that improve the detection of these compounds and the characterisation of their risk.
Researchers from IQS and IQAC are working together on the development of new synthetic methodologies where they explore the combined use of catalytic systems with the great versatility of chemical elements such as Boron, Iodine and Silicon.
IQS and COMSA Corporación have been working together since 2017 on research, technology and knowledge transfer, a successful collaboration that has so far resulted in five research projects and an industrial doctorate.
Dr. Anna del Pino recently defended her doctoral thesis at IQS, on the optimisation of the manufacturing process of sanitary quality silicone tubes. The research has been carried out within the Industrial Doctorate Plan, in collaboration with the company Venair.
Xavier Aldeguer, General Director of Knowledge Transfer, has conveyed to us the will of the Generalitat de Catalunya to increase the transfer of the university system to the productive system, within the framework of the National Agreement for the Knowledge Society.
The IQS Industrial Products Engineering Laboratory equipment has been expanded with the recent incorporation of the Form 3BL 3D printer, for the manufacture of full-scale polymeric arteries.
The GESPA group at IQS and the URV are working together on the STOP-F-GAS project, where they are studying, within the framework of the circular economy, the development of new technologies for absorbing fluorinated gases for their reuse and obtaining new, more sustainable refrigerant products.
"The HIPRA vaccine project is a big challenge and very exciting. I had never been in a project with such a degree of involvement, and with that scope. We live it with a lot of heart and with a lot of emotion "
Under the title “From an idea to the market,” the aim has been to visualize the technology transfer process from the outset when someone comes up with an idea and wants to protect it up to the signing of a license agreement with a third party
“Many of my research lines have been transferred to IQS and I expect there will be even more crossover as IQS opens up in biomedical areas in a solid bet“.
Researchers from IQS and UAM collaborate in the PhotoSMS project to develop "all-in-one" photodynamic agents capable of forming nanostructures with phototherapeutic activity.
IQS and the company Hausmann have collaborated in the development of an innovative system for the elimination of olfactory contamination in the process of water used in the manufacture of flavourings, based on its capture using graphene oxide.
The IQS Environmental Laboratory and the SCIEX_IQS Demo Lab have started to work together in the development of analytical methods for the control of cyanotoxins, using advanced HPLC-MS techniques.
Within the Collaboration Challenges program, Aortyx and the GEMAT group collaborate in the development and preclinical validation of a new endovascular medical device with localized and controlled release of anti-progression drugs for aneurysms.
The SEAT-IQS Applied Mechanics Laboratory has recently acquired a new Olympus DSX1000 digital microscope, the latest addition to the various advanced inspection and non-destructive analysis equipment that the laboratory features.
Both scientific dissemination and dissemination are communication activities. Scientific articles are the essential way to disseminate the results of a project to the scientific community, while dissemination actions are aimed at a more general public to make scientific knowledge more accessible to citizens.
The Lafora disease patients association "Chelsea's Hope Lafora Children Research Fund" has just granted Dr Jordi Duran, Professor of Bioengineering at IQS, new funding for his research on this rare neurodegenerative disease.
IQS (Ramon Llull University) and PerkinElmer have recently signed a partnership agreement to offer a new Industrial Doctorate (ID) as part of the Government of Catalonia's Industrial Doctorate Plan , co-financed between the company and the university.
“Our research, on measures of vulnerability or the fragility of social structures, can help to fulfil an objective that is very important for our university, which is supporting our social mission.”
Dr Núria Puigmal defended her doctoral thesis at IQS, where she has developed new dermal microneedles for immunotherapies, which can perform the dual function of drug release platform and treatment monitoring.
"Within the framework of the Next Generation Recovery Plan, collaboration between Academia and Business is essential, from centres such as IQS, to promote Technological Cooperation, to work together to promote the change that this country needs and to make a clear commitment to the future".
Alongside several researchers and professors from the IQS School of Engineering, IQS has once again taken part in the events and seminars held as part of the Expoquimia 2021 event to showcase the essential role of the university in technology innovation and transfer in Spain.
In the Materials Engineering Group (GEMAT) at the IQS School of Engineering, the team led by Dr Benjami Oller Salvia is working to take on two of the great challenges with GBM therapies.
Shimadzu has given IQS, through Izasa Scientific, the TQ-8050NX equipment, a triple quadrupole GCMS with advanced specifications that is used for the evaluation in the analysis of dioxins and the development of related specific methodologies.
Dr Elena de las Heras recently defended her doctoral thesis at IQS, in which she has designed and developed new photo-immuno-chemo-nanotransporters, which have shown high photodynamic activity against tumour cells and are effective and safe for the photodynamic delivery of doxorubicin on demand.
Dr Cristina García has recently defended her doctoral thesis at IQS, in which she has developed a urinary catheter equipped with a micro-and nano-structured coating with bacteriophobic characteristics, offering a clear alternative to commercial catheters.
Within the Industries of the Future community, IQS has participated in the PLASTFUN project where advanced surface functionalities and their large-scale production have been defined, and now has a validated simulation tool for optimising parameters under industrial conditions.
IQS was present at a new edition of 4YFN with its entrepreneurship centre IQS Tech Factory, consolidating its leadership position in the world of industrial technology entrepreneurship.
IQS and the company Xenopat recently signed a collaboration agreement to carry out joint research projects concerning cancer and offer services to third parties by combining both entities' experience, including ADME-Tox, computational prediction, and in vivo efficacy studies, among other pharmacokinetic studies.
The IQS Master's Degree in Bioengineering has been recognized by the El Mundo 250 Masters 2021 ranking as the best postgraduate programme in the area of Biosciences in Catalonia
El Dr. Pol Cabanach ha defendido recientemente su tesis doctoral en IQS, en la que desarrolla dos tecnologías basadas en materiales zwitteriónicos: un sistema oral de liberación de fármacos para el tratamiento de la malaria y una fotorresistencia para la microimpresión de micro-robots no-inmunogénicos.
El Dr. Germán Febas defendió recientemente su tesis doctoral realizada en el grupo GEMAT de IQS, donde ha desarrollado y patentado un dispositivo médico que sella el orificio realizado en la membrana corioamniótica después de una fetoscopia, con el objetivo final de reducir el riesgo de rotura de esta membrana y salvar la vida del futuro bebé.
El profesor de IQS, el Dr. Octasiano Valerio Mendoza lidera el proyecto Chinequaljustice, que tiene el objetivo de estudiar las desigualdades económicas y sociales en China, desde un modelo económico novedoso basado en la teoría Capability Approach, entendiendo el bienestar en términos de las capacidades y del funcionamiento de las personas.
IQS Tech Transfer y la empresa Vision Arcanum colaboran en un proyecto para el reconocimiento digital de estructuras químicas dibujadas a mano, en pantalla táctil o en papel, utilizando modernas técnicas de visión por ordenador (Modern Computer Vision Techniques) basadas en Machine Learning.
BASF has contributed to the construction of the Advanced Nanotechnology and Materials Laboratory with the IQS Process Transfer and Integrative Technologies Centre (CTPTI).
IQS firmly believes that patents are of vital importance and that they allow us to position ourselves in certain industrial environments. They add value to what we do and are a way of transferring the results of our scientific activity to society. For this reason, we aim for every patent application to be accompanied by a strategy for its commercialization via a license to a company or a spinoff that makes its industrial application viable.
“I am a scientist at heart, that science is very important, and that it only translates into a benefit for society when it is conducted with ethical values such as rigour, transparency, and integrity. These values were instilled in me during my education at IQS”.
IQS dispone de un nuevo equipo de ultra gama, SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP®, instalado en el recientemente creado IQS-SCIEX Demo Lab, que permitirá ampliar las posibilidades de investigación avanzada y la oferta de transferencia de tecnología a la industria.
Researchers from IQS have been part of the REGiREU project, in which the objective is to replace the current management of the water cycle with a model in accordance with the principles of Circular Economy, leading the study to replace mercury lamps with UV- LEDs.
Researchers from IQS are part of the NeuroTICs project, a consortium created to establish a new generation of therapeutic agents against poisoning by neurotoxic agents, as well as to determine their action, using zebrafish and rodent models for the study.
On 10 May 1991, the proposal to create Ramon Llull University was unanimously approved by the Parliament of Catalonia, under Law 12/1991, published in the Official Gazette of the Government of Catalonia (DOGC).
Researchers from IQS have participated in the TRANSPORT project, leading the development and optimization activities of "lattice" type structures to achieve lighter parts through 3D printing, thus providing knowledge and experience in the field of additive manufacturing.
Within the framework of the QuirofAM project, the CIM center, the IQS GEMAT group and the Tractivus spin-off, have co-developed a 3D printer that allows printing of medical grade silicone for the manufacture of medical devices. As a first demonstrator, the researchers have developed a completely customized tracheal stent.
The Biochemistry Laboratory at IQS has analysis techniques to verify if the protein hydrolysates comply with European standards which limits the presence of proteins with a molecular weight over 10kDa.
“Formar parte del Patronato de la Fundación IQS es para mí una oportunidad de intercambio de conocimientos, de aprendizaje y, por qué no, de perseguir el sueño de que IQS sea el referente de sostenibilidad, en el sentido más amplio, dentro de UNIJES”.
In front of the Next Generation stage, we all have an extraordinary opportunity that we must seize, not only to recover, but also to come out even stronger and make way for the Next Generation.
Beatrice is a doctoral Student in Industrial Engineering with the Department of Chemical Engineering and Materials Science at the IQS School of Engineering.
The offer of R&D&i services that IQS Tech Transfer provides companies has been expanded since 2020 with the launch of the Continuous Chemical Processes Unit, installed in the CTPTI at IQS, which is aimed at improving fine chemistry processes to make them safer, faster, and cleaner.
With Process Analytical Technology (PAT), it is possible to monitor the reactions that take place in the Flow Chem Unit reactors. Moreover, any substance or mixture can be characterized with the equipment in the Thermal Analysis Laboratory (DSC and TGA).
The facilities and equipment at the CTPTI Continuous Chemical Processes Unit make it possible to apply new advanced manufacturing technologies in fine chemicals, which opens up the possibility of comprehensively developing safer, faster, and cleaner chemical processes.
"Collaboration between companies and research centres is beneficial for both parties, because it's a source of technological ideas and possibilities and because it provides knowledge about what the market is looking for and what it needs."
Through the publication and dissemination of this special issue dedicated to the Continuous Chemical Processes Unit, we would like to present the facility, the equipment and instruments that comprise it, the various services that we can offer to industry, and the excellent personnel without whom the project would not be a reality.
La tesis doctoral defendida recientemente por el Dr. Mario López está centrada en terapias duales para el tratamiento de enfermedades cardiovasculares y antimicrobianas, basadas en la administración de óxido nítrico, introducido en vectores poliméricos de pBAE.
“We want that when a student joins the IQS family, they feel that they're supported by IQS for their entire life, even beyond their period as a student, IQS will be by their side throughout their professional life. IQS offers all the elements to provide COMPREHENSIVE value to our stakeholders, and we must take advantage of all this to the fullest. ”
IQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.
IQS researchers of the Endovascular Repair Patch project, carried out within the AGAUR 'Product' call, have achieved both the definitive design of the deployer and the biocompatible materials that allow the administration of a patch for the repair of arteries affected by aortic dissection .
To everyone who contributes to IQS through donations, sponsorships, or patronage, we thank you all. We will never tire of acknowledging your commitment to IQS. We know that you are here with us and that we can count on you.
In her doctoral thesis carried out at IQS School of Management, Dr. Nour Chams shows the impact of the human factor and financial indicators on sustainability performance in a group of companies with an international perspective.
In her doctoral thesis carried out in the Department of Bioengineering of IQS, Dr Núria Orive designed different metabolic engineering strategies to increase the production of glycoglycerolipids, interesting products due to their potential use as vaccine adjuvants or tumor suppressors.
“We have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4ºC, and obtained through an easily scalable process.“
In July 2018, public health authorities became aware of the presence of the N-nitrosodimethylamine (NDMA) impurity in Valsartan batches for the first time. In the following months, other nitrosamines in drugs were detected from the same family (sartans), such as Ibersartan or Losartan, and in other drugs such as pioglitazone, ranitidine, and metformin.
In 2005, the European Commission adopted a European Charter for Researchers and a Code of Conduct for the Recruitment of Researchers with the aim of making research careers in Europe more attractive. It also promoted the HRS4R (Human Resources Strategy for Research) strategy to support universities, research institutions, and organisations that fund research with the ultimate goal of contributing to the development of an attractive European labour market for researchers.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
